According to a research report published by Spherical Insights & Consulting, the Global Breast Biopsy Devices Market Size is Expected to Grow from USD 1.7 Billion in 2023 to USD 2.9 Billion by 2033, at a CAGR of 5.49% during the forecast period 2023-2033.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4449

Breast biopsy devices are medical equipment and instruments that are employed in the removal of tissue samples for diagnosis from the breast. They are designed for the detection and diagnosis of abnormalities, such as lumps, calcifications, or masses, which can indicate conditions like breast cancer or benign diseases in the breast. Several methods, such as fine-needle aspiration, core needle, stereotactic, ultrasound-guided, MRI-guided, and surgical biopsy, are employed for performing breast biopsies. Breast biopsy carries certain hazards, such as breast bruising and swelling, bleeding or infection at the biopsy site, and changes in breast appearance. Furthermore, breast cancer is a leading cause of death for women worldwide. Market growth is driven by rising awareness of breast cancer prevention campaigns. The market is growing due to the quick recovery and reduced pain associated with minimally invasive surgeries, which are becoming more and more popular among patients. Costly funding as well as grants for biomarker research are driving the market expansion for breast biopsy devices. However, the high costs, limited access to healthcare, regulatory hurdles, patient reluctance, competition from non-invasive methods, reimbursement challenges, and socioeconomic disparities.

Browse 210 market data Tables and 45 Figures spread through 190 Pages and in-depth TOC on the Global Breast Biopsy Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, and Others), By Technique (Image Guided Biopsy and Liquid Biopsy), By End-User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

      Buy Now Full Report; https://www.sphericalinsights.com/checkout/4449

The biopsy needles segment is expected to hold the greatest share of the global breast biopsy devices market during the forecast period.

Based on the product, the global breast biopsy devices market is divided into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and others. Among these, the biopsy needles segment is expected to hold the greatest share of the global breast biopsy devices market during the forecast period. This is attributed to the biopsy needles that are used detect the origin of abnormalities, and a thin, hollowed needle and syringe are used to collect samples, such as cells, fluids, or tissues from a suspected mass or another abnormal part of the body having low-cost and sophisticated enough for surgeons and radiologists.

The liquid biopsy segment is expected to hold the greatest share of the global breast biopsy devices market during the forecast period.

Based on the technique, the global breast biopsy devices market is divided into image guided biopsy and liquid biopsy. Among these, the liquid biopsy segment is expected to hold the greatest share of the global breast biopsy devices market during the forecast period. This is attributed to the method such as liquid biopsy which is a cutting-edge method that expands the scope of cancer diagnosis. The market has certainly expanded greatly as an outcome of the increasing usage of droplet digital PCR technology and modern NGS-based assays for liquid biopsies in most industrialized countries.

The hospitals segment is expected to hold the greatest share of the global breast biopsy devices market during the forecast period.

Based on the end-user, the global breast biopsy devices market is categorized into hospitals, ambulatory surgical centers, diagnostic centers, and others. Among these, the hospitals segment is expected to hold the greatest share of the global breast biopsy devices market during the forecast period. This is caused by the large number of patients that hospitals treat and diagnose with breast cancer. Also, companies are focusing on innovative methods to train hospital surgeons and radiologists to reach more patients, and these have started to gain recognition. depending on cutting-edge facilities and skilled experts to smoothly integrate intricate biopsy procedures.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/4449

North America is expected to hold the greatest share of the global breast biopsy devices market over the projected timeframe.

North America is expected to hold the greatest share of the global breast biopsy devices market over the projected timeframe. The two most significant financial states in this region, the United States and Canada, are the elementary revenue generators for market expansion. Modern medical facilities, worldwide access to cutting-edge diagnostic tools, and a vibrant breast cancer awareness campaign are the factors propelling the United States to the forefront of the sector. Furthermore, the primary factors propelling the growth of the breast biopsy device market over the anticipated timeframe are the increasing number of breast cancer patients, growing awareness of early detection of breast cancer, more effectively government funding for breast cancer research, and the growing use of devices in U.S. cancer research centers.

Asia-Pacific is expected to grow at a rapid rate in the global breast biopsy devices market over the projected timeframe. The market is expanding as a result of investments made by the region’s fastest-growing nations in the construction of healthcare facilities. Furthermore, as the diagnostic market in developing nations grows more aware of breast biopsy techniques, businesses can invest in breast biopsy equipment in these markets. In nations like China, South Korea, and India, rapid advancements in health technology have driven up the cost of innovative technologies for hospitals and other breast care facilities. The market for breast biopsy devices is expected to grow over the forecast period due to these factors.

Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global breast biopsy devices market are Becton Dickinson and Company, Cook Medical Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Medax Srl Unipersonale, Scion Medical Technologies, LLC, ARGON MEDICAL, C.R. Bard, Inc., Devicor Medical Products, Inc., GE Healthcare, Leica Biosystems, Siemens Healthier, Medtronic plc, Cardinal Health, INRAD Inc, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Key Market Development

• In May 2023, Argon Medical Devices, a leading provider of medical devices, launches the Advantage Semi-Automatic Biopsy Instrument in the United States., growing its soft tissue biopsy product line. Increasing revenue and changing the company’s contribution were the main goals of this planned introduction.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global breast biopsy devices market based on the below-mentioned segments:

Global Breast Biopsy Devices Market, By Product

• Biopsy Needles
• Guidance Systems
• Biopsy Tables
• Localization Wires
• Assay Kits
• Liquid Biopsy Instruments
• Others

Global Breast Biopsy Devices Market, By Technique

• Image Guided Biopsy
• Liquid Biopsy

Global Breast Biopsy Devices Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Other

Global Breast Biopsy Devices Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

Browse Related URL’s:

Global Animal Genetics Market Size, Share, and COVID-19 Impact Analysis, By Type (Assistive Reproduction Technologies, Live Animals, and Genomic/ Genetic Testing), By End-User (Veterinary Hospitals & Clinics, Research Centers & Institutes, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033

Global RNA Targeted Therapeutics Market Size, Share, and COVID-19 Impact Analysis, By Type of Target Molecule (Cap Binding Complex, CDKL5, Dystrophin Protein, G542X, MNK1/MNK2, PAX6 gene, and SMN2), By Type of Approach (Indirect RNA Targeting, mRNA Translation Modulation, and RNA Splicing Modification), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

Global Antiemetics Drugs Market Size, Share, and COVID-19 Impact Analysis, Drug Type (Serotonin-Receptor Antagonists, Anticholinergics, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, and Others), By Application (Chemotherapy, Gastroenteritis, Post Operative Surgery, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035

Global Technology Spending On Core Administration in Healthcare Market Size, Share, and COVID-19 Impact Analysis By Solution (Hardware, Software, and Services), By Deployment (Cloud-Based and On-Premise), By End User (Payers and Providers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter